The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cavhanza
Nilotinib · NILOTINIB 80 mg/1 · Tablet, Orally Disintegrating · Oral · Cycle Pharmaceuticals Ltd
NDC 70709-0192-12 · 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA217379
- TE code
- —
- Approval date
- May 29, 2026
- Patents / exclusivity
- 8 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11559485 | Apr 30, 2041 |
| patent | 11559485 | Apr 30, 2041 |
| patent | 11389450 | Jan 29, 2041 |
| patent | 11389450 | Jan 29, 2041 |
| patent | 12016861 | Jan 29, 2041 |
| patent | 12029740 | Jan 29, 2041 |
| patent | 12029740 | Jan 29, 2041 |
| patent | 12016861 | Jan 29, 2041 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nilotinib (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cycle Pharmaceuticals Ltd | NILOTINIB 60 mg/1 | Jul 22, 2026 | Sep 3, 2026 |
| Cycle Pharmaceuticals Ltd | NILOTINIB 80 mg/1 | Jul 22, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cavhanza — NDC 70709-0192-12," retrieved September 3, 2026, https://drugdashboards.com/drug/70709019212.
Free to cite with attribution — see how the data is put together.